DRIVE-AB final conference : New economic models for much needed innovative antibiotics presented at the (5-6 september 2017, Brussels). (June 1st 2017)
The DRIVE-AB project is part of the IMI’s New Drug For Bad Bugs (ND4BB) initiative. Its objective is to propose innovative economic models relevant for revitalizing the Antibiotics pipeline with appropriate push and pull incentives.
After 3 years of work the DRIVE-AB consortium will present its results on the occasion of its final conference.